
Jonathan Schott
professorMale0.0Global Dominance: 0.00%
Jonathan Schott is the chief medical officer at Alzheimer’s Research UK and a neurology professor at University College London. He co-authored critiques on the definitions of Alzheimer’s disease, stressing that current biomarker-positive tests should be viewed as indicators of risk rather than definitive diagnoses, as research continues to evolve in this field.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Jonathan Schott emphasizes that biomarker-positive tests should indicate risk rather than proof of disease.
When is the correct time to diagnose dementia? | ScienceThe Guardian·
United Kingdom· 2025-02-23





